Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitors

Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitors

US Patent 12257245 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Self-assembling synthetic proteins comprising cholera toxin beta subunit2025
Methods and compositions for inhibition of EGF/EGFR pathway in combination with 2025
Synthetic proteins and therapeutic uses thereof2024
Recombinant proteins and their therapeutic uses2024
Self-assembling synthetic proteins2022
Recombinant proteins and their therapeutic uses2021
Epidermal growth factor fusion proteins with mutant cholera toxin B subunits2020
Process for producing influenza vaccine2019
Recombinant proteins and their therapeutic uses2018
Process for producing influenza vaccine2017
Composition2007